Michael D. Capellas

b. 1955

Sits on 4 boards. Last updated September 28, 2026

Time on boards

Boards served
4
Current seats
4
Board service
10 years
Director since
2023

10 years of board service in total across 4 boards, counting each seat separately. Longest: SkinHealth Systems Inc., 3 years.

3 years · Since 2023
Flex Ltd. Director
3 years · Since 2023
2 years · Since 2023
7 months · Since 2026

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Dec 19, 2025 Cisco Systems Inc. Open-market sale −10,850 $77.13 $836,861
Dec 18, 2025 Cisco Systems Inc. Open-market sale −16,150 $77.28 $1,248,072
Dec 16, 2025 Cisco Systems Inc. Grant or award +3,481 — —
Dec 9, 2024 Cisco Systems Inc. Grant or award +4,156 — —
Jul 8, 2024 SkinHealth Systems Inc. Grant or award +78,534 — —
May 28, 2024 Flex Ltd. Open-market sale −78,872 $33.64 $2,653,254
Dec 6, 2023 Cisco Systems Inc. Grant or award +5,136 — —
Aug 17, 2023 SkinHealth Systems Inc. Open-market purchase +30,000 $6.03 $180,900
Aug 2, 2023 Flex Ltd. Grant or award +7,418 — —
Aug 2, 2023 Flex Ltd. Grant or award +3,709 — —
Jun 14, 2023 SkinHealth Systems Inc. Grant or award +16,357 — —
May 14, 2021 SkinHealth Systems Inc. Other +136,162 — —

Questions about Michael D. Capellas

What boards is Michael D. Capellas on?

Michael D. Capellas sits on the boards of Cellebrite DI Ltd., Cisco Systems Inc., Flex Ltd. and SkinHealth Systems Inc.

How long has Michael D. Capellas served on boards?

Our records show at least 10 years of board service across 4 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.